EVALUATION OF PATIENT-SPECIFIC IMRT QUALITY ASSURANCE AND POINT DOSE MEASUREMENT FOR COMPLEX HEAD AND NECK AND BRAIN CANCER USING GAFCHROMIC EBT3 FILM.

Abstract

Patient-specific intensity-modulated radiation therapy (IMRT) quality assurance (QA) is essential for complex radiotherapy treatment as it involves complex intensity modulation and high-dose gradient regions. IMRT QA was performed by point dose verification and two-dimensional (2D) dose distribution measurement using gamma method. Calibrated External Beam Therapy 3 (EBT3) film was used for point dose and pre-treatment verification of 10 IMRT plans, five complex Head and Neck (HN) and five brain cases. The gamma passing rate (GPR) was evaluated for 3%/3mm gamma criteria and compared with 2D array. Isocentre dose was measured for all 10 IMRT plans on EBT3 film. Percentage deviation of point dose measurement from TPS calculated was found 0.4% for brain cases and 2.9% for HN cases. The GPR for 3%/3mm criteria was obtained higher than 95% for brain and HN cases. Results suggest that film dosimetry is also a reliable verification system for patient-specific IMRT QA as the 2D array.